Quarterly report · Q2
4272.TEDINET S100S30O
Period2023-04-01 → 2023-09-30
Filed2023-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥97.9bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥198.4bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥102.7bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥4.8bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥13.6bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥8.3bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥23.0bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥16.6bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥8.8bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥16.4bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥6.1bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥15.0bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥11.3bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥6.1bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥11.3bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥349.2bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥322.9bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥329.5bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥81.7bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥67.8bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥267.5bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥255.0bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥259.2bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥50.5bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥48.1bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥57.2bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥53.1bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥52.6bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥53.0bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥10.5bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥20.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥12.0bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥12.2bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥15.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥9.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥2.3bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥8.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥6.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥36.74 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥20.69 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥89.36 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥67.04 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥31.63 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥36.72 | 2023-04-01 → 2023-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥89.33 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥67.02 | 2022-04-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 76.3% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.7% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.4% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥78m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥78m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥3.9bn |
| jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥28.0bn |
| jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥27.9bn |
| jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥77m |
| jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥2.3bn |
| jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥30.5bn |
| jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥30.5bn |
| jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥0 |
| jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥3.1bn |
| jpcrp040300-q2r_E00836-000Mobility And Imaging Business Unitreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥39.5bn |
| jpcrp040300-q2r_E00836-000Mobility And Imaging Business Unitreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥39.5bn |
| jpcrp040300-q2r_E00836-000Mobility And Imaging Business Unitreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥3.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥98.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥97.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥78m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥8.7bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥82m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥82m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥3.7bn |
| jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥36.7bn |
| jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥36.6bn |
| jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥82m |
| jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥7.2bn |
| jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥30.0bn |
| jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥30.0bn |
| jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥0 |
| jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥5.4bn |
| jpcrp040300-q2r_E00836-000Mobility And Imaging Business Unitreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥36.2bn |
| jpcrp040300-q2r_E00836-000Mobility And Imaging Business Unitreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥36.2bn |
| jpcrp040300-q2r_E00836-000Mobility And Imaging Business Unitreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥4.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥102.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥102.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥82m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥17.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 573
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)ＥＹ新日本有限責任監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)春 日 淳 志 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)清 水 幹 雄 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 102728000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 97908000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 198380000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 16628000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 8313000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 23025000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 11281000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 6092000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 14984000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 16935000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 16692000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 19050000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 259239000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 267540000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 255027000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 329503000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 349247000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 322858000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 67.04 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 36.74 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 89.36 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | 67.02 | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | 36.72 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 89.33 | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.784 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.763 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.787 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 12035000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | 10523000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 20039000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -9238000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -12157000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -15158000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | -6198000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | 2340000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -7950000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 52613000000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 57172000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 53096000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 31.63 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | 20.69 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 170503570 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 170503570 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 170503570 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 170503570 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |